drugset / Trial / NCT02404298
Transcriptome Analysis of the Peripheral Blood in CIDP
NaSingle-groupOpen-labelTreatment
Summary
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated disorder of peripheral nerves. Intravenous immunoglobulins (IVIg) are a first line therapy for CIDP. The investigators used a transcriptomic approach to compare the gene expression profiles in the peripheral blood of patients having a CIDP or autoimmune diseases, before and after IVIg treatment, in order to identify their mechanism of action in this condition, to lead to a better understanding of CIDP pathophysiology, and potentially determine factors associated with the response to the treatment.
Timeline
- Start
- 2015-02
- Primary completion
- 2018-01
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Intravenous immunoglobulins | Protein / enzyme biologic | — | Intravenous |